Nanoform appointed Antonio da Silva as CBO and a member of the management team as of January 1st, 2023. Antonio da Silva has an extensive background in the CDMO and particle engineering space, having worked for 19 years at Hovione, where he took part in several pharmaceutical product launches. Antonio has been with Nanoform since 2019 when he joined as Director, Quality Control.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.155 EUR | +6.16% | -15.16% | +35.96% |
Apr. 11 | Nanoform Finland to Deliver Nanomedicine Technology to Japan | MT |
Apr. 11 | Nanoform Enters Exclusive Partnership with CBC to Bring Best-In-Class Nanomedicine Technology to Japan | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.96% | 197M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- NANOFH Stock
- News Nanoform Finland Oyj
- Nanoform Appoints Antonio Da Silva as Chief of Business Operations and Member of the Management Team